This comprehensive five-country report contains 820 pages, 320 tables, and presents analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the European cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.
Cancer Diagnostic Tests
ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA, Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG, Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar, Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone, Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein, Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin, Tissue Polypeptide Antigen, and others.
France, Germany, Italy, Spain, UK
Market Segmentation Analysis
Current and Emerging Products
Strategic assessments of major suppliers and start-up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.
Business Opportunities and Strategic Recommendations
Contains 820 pages and 320 tables
SIMILAR MARKET STUDIES
This new report from Venture Planning Group contains 887 pages, 72 tables, and presents a comprehensive analysis of the Italian hospital infectious disease testing market, including:
December 2013 | $2900 | View Details >>
Notes: Sales, means the sales volume of Fire Hose Cabinets Revenue, means the sales value of Fire Hose Cabinets This report studies sales (consumption) of Fire Hose Cabinets in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Ventura Fibres Fire-End & Croker ...
February 2017 | $3800 | View Details >>
This DataPack contains tables from VPGMarketResearch.com new report, 2016 New Frontiers in the Global Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape. For pricing information on DataPack sections or individual tables, please contact Customer Service.
February 2016 | $0 | View Details >>
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Italian Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The report provides test volume and sales projections for Hospitals and ...
January 2014 | $1450 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research